IMR Press / EJGO / Volume 34 / Issue 6 / pii/1630906513074-1263923878

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research
Is the 2009 FIGO staging system really valuable for Stage I endometrial cancer?
Show Less
1 Department of Obstetrics and Gynecology, Ankara Oncology Education and Research Hospital, Ankara (Turkey)
Eur. J. Gynaecol. Oncol. 2013, 34(6), 556–558;
Published: 10 December 2013

Purpose: The aim of this study was to compare the survival predictive values of the 1988 and 2009 FIGO staging systems for the staging of patients with early-stage endometrioid type endometrial cancer. Materials and Methods: Two hundred twenty-four patients treatedfor endometrial cancer from 1996 to 2006 at Ankara Oncology Education and Research Hospital were staged according to the two staging systems. Early-stage patients with a histological diagnosis of endometrioid adenocarcinoma were included in the study. The Kaplan-Meier method was used for survival analysis. Results: The charts of 224 patients treated for endometrial cancer were retrospectively evaluated. The five-year overall survival (OS) for Stage IA and IB cases was 100% (n = 19) and 96.2% (n = 79), respectively, with no significant difference between the OS values (p = 0.126) with the FIGO 1988 system and 96,4% (n = 112) and 87.5% (n = 48), respectively with a statistically significant difference (p = 0.05) with the FIGO 2009 system. Conclusion: The authors found that the survival prognostic value of the 2009 FIGO staging system was more effective than the 1988 FIGO staging system for cases with early-stage endometrioid type endometrial cancer.
Endometrial cancer
Staging system
Back to top